Investigating the effect of fentanyl from the nasal mucosa with intravenous fentanyl as a pre-moderate on the vital signs of patients undergoing general anesthesia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240727062550N1

Enrollment

Registered

2024-08-11

Start date

2024-08-22

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systolic blood pressure. Postprocedural disorders of circulatory system, not elsewhere classified

Interventions

Intervention 1: Intervention group: Mucosal drug administration. Intervention 2: Intervention group: Administration of drugs by injection.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 65-18 years Candidate for elective surgery under general anesthesia Informed consent to participate in this study

Exclusion criteria

Exclusion criteria: Hypersensitivity or allergy to fentanyl History of substance abuse History of food intolerance History of cardiovascular, liver or kidney diseases Pregnancy or breastfeeding

Design outcomes

Primary

Measure	Time frame
Systolic blood pressure. Timepoint: One, three, five, seven, and thirteen minutes after drug administration. Method of measurement: monitoring.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Sami

Islamic Azad University

alisamiee777879@gmail.com+98 21 2660 2642

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026